Cambridge Heart wins FDA 510(k) clearance for OEM cardiac test

April 15, 2010 by MassDevice staff

Cambridge Heart Inc.'s plan to enter the original equipment manufacturing market gets a big boost as the Food & Drug Administration grants 510(k) clearance to its MTWA heart testing module.

CAMH logo

Cambridge Heart Inc. (OTC:CAMH) won a much-needed nod from the Food & Drug Administration when the watchdog agency cleared an OEM version of its microvolt T-wave alternans cardiac monitor.

The 510(k) clearance means the Tewksbury, Mass.-based firm can move forward with a deal it struck last year with Cardiac Science Corp. (NSDQ:CSCX) to incorporate the MTWA device into Cardiac Science's Q-Stress line of heart stress-testing equipment.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.